MOPE Clinic pushes hematocrit monitoring in testosterone therapy

MOPE Clinic in Metairie is spotlighting hematocrit, CBC testing and blood pressure monitoring for patients on testosterone replacement therapy after updated national guidance on testosterone diagnosis and oversight. The clinic says routine follow-up matters because testosterone can raise red blood cell counts, and other factors like dehydration and sleep apnea can also affect lab results.

Why it matters: - Testosterone replacement therapy can affect more than hormone levels. Hematocrit, hemoglobin, blood pressure and symptoms can all change during treatment. - Elevated hematocrit can signal too many red blood cells, but it can also reflect dehydration, smoking, sleep-disordered breathing or other medical issues. - The shift matters for patients in South Louisiana, where heat and heavy sweating can complicate lab interpretation.

What happened: - MOPE Clinic is expanding patient education on hematocrit and complete blood count monitoring for testosterone replacement therapy. - The push follows renewed attention to testosterone testing, diagnosis and medical oversight after the Endocrine Society issued a July 16, 2026 statement on testosterone replacement therapy. - Chris Rue, APRN, FNP-C, said testosterone monitoring requires more than one number and includes blood counts, blood pressure, symptoms and overall response. - MOPE Clinic published additional educational information at the clinic's article.

The details: - Hematocrit measures the share of blood volume made up of red blood cells and is generally included in a complete blood count, or CBC. - Testosterone can stimulate red blood cell production, so hematocrit and hemoglobin can rise in some patients during treatment. - The Endocrine Society said testosterone deficiency should be diagnosed using both clinical symptoms and consistently low, accurately measured testosterone levels. - The Endocrine Society also said symptoms alone are not enough for diagnosis and that reversible causes should be evaluated before treatment is recommended. - The American Urological Association recommends measuring hemoglobin and hematocrit before testosterone therapy and monitoring those values during treatment. - American Urological Association guidance identifies hematocrit below 54% as a treatment monitoring goal. - Clinicians may look at the rate of change, baseline values, testosterone levels and medication dose instead of relying on a single lab result. - Dehydration can make red blood cell concentration appear higher because plasma volume drops. - Heavy heat and humidity in Metairie, New Orleans, Kenner, Covington, Mandeville, Slidell and nearby communities can contribute to fluid loss. - Obstructive sleep apnea can also raise red blood cell production because repeated drops in oxygen may trigger the body to make more red blood cells. - Fatigue, poor concentration, weight gain and reduced performance can overlap between low testosterone and sleep apnea. - Blood pressure monitoring has become more relevant during testosterone treatment. - In February 2025, the FDA announced class-wide labeling changes for testosterone products after reviewing the TRAVERSE cardiovascular trial and ambulatory blood pressure monitoring studies. - The FDA removed earlier boxed-warning language about increased cardiovascular outcomes and added new or updated warnings about increased blood pressure. - The FDA requested additional testosterone prescribing-information updates in June 2026 after reviewing newer evidence. - MOPE Clinic requires laboratory testing before treatment and says treatment plans are individualized based on clinical evaluation, symptoms and lab findings. - MOPE Clinic is LegitScript-certified and operates as a physical medical clinic rather than a virtual-only prescription service.

Between the lines: - The guidance underscores a broader shift in testosterone care toward ongoing monitoring instead of one-time prescribing decisions. - Rising hematocrit does not automatically mean testosterone therapy should stop, and it does not automatically mean blood donation is the right answer. - Therapeutic phlebotomy may be used in some patients, but repeated blood donation can affect iron stores and should not replace evaluation of why hematocrit increased. - The clinic's advice reflects a more individualized approach, where symptoms, trend lines and other health factors shape next steps.

What's next: - Patients on testosterone therapy should expect follow-up labs that may include hormone levels, CBC measurements, blood pressure and other testing based on age, history and treatment plan. - MOPE Clinic says future care decisions should be based on baseline testing and trends over time, not a single result. - Patients with loud snoring, breathing pauses during sleep, morning headaches or persistent daytime fatigue may need further evaluation for sleep apnea. - Patients should not change testosterone dosing, start aspirin or begin blood donation without medical guidance.

The bottom line: - MOPE Clinic is using updated testosterone guidance to stress that safe TRT depends on baseline labs, ongoing CBC monitoring and individualized follow-up rather than testosterone levels alone.